Overview of 5 Yr Outlook

PHM017E In Vitro Toxicity Testing: Technologies and Global Markets

Robert G. Hunter January 7, 2014


The goal in conducting this study was to update the status of the global in vitro toxicity testing market and assess its growth potential over the five-year period from 2012 to 2017. We were particularly interested in understanding the current market adoption, and analyzing drivers for increasing this in terms of both scope (more applications) and scale (larger volume applications).

In addition, we were interested in understanding the impact of these methods on different industry sectors, specifically the pharmaceutical, cosmetic and chemical industries. Another key objective was to analyze the adoption of in vitro toxicity testing in developed and emerging markets.

Classical toxicology testing programs have been in place for many decades now. Over the past 20 years, animal welfare and scientific activities have spurred the development of alternative testing methods.

This report details the recent key technical advances in different toxicology categories, and the extent of adoption by commercial customers and regulatory authorities. It also identifies the impact of new bioinformatics advancements and examines their growth potential.

There are many groups of suppliers that provide equipment, assays, cells, reagents, and services used in toxicity testing. Previously, there was broad coverage of the services landscape, and this study sought to analyze the others in greater depth.


The scope of the report encompasses the major types of traditional toxicity testing that have been used, and the in vitro techniques that are being developed by industry, government agencies and nonprofits. It analyzes current market status, examines drivers on future markets and presents forecasts of growth over the next five years.

Technology developments, including the latest trends, are discussed. Other influential factors such as validation and testing strategies for pharmaceuticals, cosmetics, and chemicals have also been included.

Regulatory drivers play a large role in toxicology, determining the specific parameters of tests that have been explicitly required. They also heavily influence the testing that is performed by companies in earlier stages of research. The report examines the regulatory role and the different federal and international agencies that play an active role in in vitro toxicology research, development and adoption.

Predictive Toxicology

The term ‘predictive’ is often used in conjunction with in vitro toxicology, and historically predictive approaches (also called ‘nonmechanistic’) have been contrasted with mechanistic approaches. This report does discuss where applicable the relative magnitude of the two. However, our research shows that increasingly the two are used in tandem, and that they are being viewed as complementary parts of an overall toolkit. Thus, our use of the term ‘Predictive Toxicology’ as a subject/discipline throughout is intended to encompass both predictive and mechanistic, and to connote an evolution of the overall toolkit. In keeping with the ‘Tox 21’ vision detailed later, the key attribute of this overall evolution is being more and more able to use in vitro methods to predict in vivo outcomes.

Intended Audience and Approach Taken

This report is designed to satisfy the information needs of a wide variety of individuals involved in the toxicology, in vitro and in silico marketplaces, including company senior management executives seeking to base their strategic decisions on the latest insights into toxicology market forces and trends. It is also aimed at managers and executives in product research and development and particularly those responsible for bringing new products to market.

Both primary and secondary research methodologies were used in preparing this study. Primary research included interviews with leading individuals in relevant companies and associations; primary sources of published data included research studies, company annual reports and government publications. Secondary sources consisted of literature searches, industry journals and other commercial publications. Data for market estimates and forecasts are pooled from a range of sources, critically assessed by BCC Research.

Again, look for report #PHM017E and ask about the possibility of a free call with the author!  BCC Research offers an online information retrieval service and other information at www.bccresearch.com.

Better results, less side effects